Comment from The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG)

Summary: The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) opposes the citizen petition seeking to relax FDA regulations on mifepristone. They argue that the drug poses significant safety risks, citing real-world data on complications, and urge the FDA to reinstate pre-2016 Risk Evaluation and Mitigation Strategies (REMS) including mandatory in-person dispensing and reporting of all adverse events.